Brian is a partner at SEP and focuses on investments across the healthcare and life sciences sectors. He has 16 years experience of investing in healthcare and has been responsible for a significant number of deals with companies pioneering world class technology in this area.
Brian led SEP’s investments in: Stentys, a medical device company treating coronary heart disease; Heartscape, a company marketing an ECG system with superior diagnostic capabilities; Arakis, which was acquired by Japanese biopharmaceutical company Sosei; BioVex, a cancer therapeutics company, and hospital billings systems company Craneware which recently floated on AIM. He is on the board of Heartscape.
